GL1X · GenesisL1 explorer

MolNFT v1 · #124143 · protein

Human phospodiesterase 4B in complex with pyridyloxy-benzoxaborole based inhibitor

5K6J · Camp-specific 3',5'-cyclic phosphodiesterase 4B: “Human phospodiesterase 4B in complex with pyridyloxy-benzoxaborole based inhibitor”. X-ray diffraction, 3 ligands (6QQ, ZN, MG), 2 pockets (best druggability 0.74). MolNFT v1 #124143…

PDB
5K6J
Type
protein
Length
323 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Camp-specific 3',5'-cyclic phosphodiesterase 4B
EC
3.1.4.53
UniProt
Q07343
Ligands
6QQ, ZN, MG
Pockets
2 · best druggability 0.74

Structure

x-ray diffraction · 1 distinct chain · 67% helix, 1% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACamp-specific 3',5'-cyclic phosphodiesterase 4B (EC 3.1.4.53)protein32367% helix, 1% strandQ07343

Ligands and binding sites

  • 6QQ · 6-[[7,7-bis(oxidanyl)-8-oxa-7-boranuidabicyclo[4.3.0]nona-1(6),2,4-trien-3-yl]oxy]-5-chloranyl-2-(4-oxidanylidenepentoxy)pyridine-3-carbonitrile · ligand · chains A
  • ZN · Zinc ion · metal · chains A
  • MG · Magnesium ion · metal · chains A
  • EDO · 1,2-ethanediol · additive · 17 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14590.740.8340MG, 6QQ, EDO
2520.270.7514empty

Compared structures

  • 5K6J · Human Phospodiesterase 4B in complex with pyridyloxy-benzoxaborole based inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.